Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
Radioimmunotherapy (RIT) represents a selective internal radiation therapy, that is, the use of radionuclides conjugated to tumor-directed monoclonal antibodies (including those fragments) or peptides. In a clinical field, two successful examples of this treatment protocol are currently extended by...
Saved in:
Main Author: | Hidekazu Kawashima |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/492061 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy
by: Suxia Han, et al.
Published: (2014-01-01) -
New Antibody Conjugates in Cancer Therapy
by: Serengulam V. Govindan, et al.
Published: (2010-01-01) -
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
by: Xiaojie Chu, et al.
Published: (2024-12-01) -
Inhibition of cancer cells using target-specific 2A3 antibody-conjugated gold nanoclusters
by: Jui-Chi Kuo, et al.
Published: (2022-03-01) -
Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy
by: Xiaopeng Li, et al.
Published: (2024-12-01)